Iqra holds a MSc in Cellular and Molecular Medicine from the University of Ottawa in Ottawa, Canada. She also holds a BSc in Life Sciences from Queen’s University in Kingston, Canada. Currently, she is completing a PhD in Laboratory Medicine and Pathobiology from the University of Toronto in Toronto, Canada. Her research has ranged from across various disease areas including Alzheimer’s disease, myelodysplastic syndrome, bleeding disorders and rare pediatric brain tumors.
Therapies based on compassion are more cost-effective and associated with a better quality of life than are those using relaxation techniques to help people with fibromyalgia, a study reported. ... Read more
Adding medical cannabis to standard pain relief therapy leads to clinical improvements in a significant proportion of patients with fibromyalgia, particularly among those with sleep problems and a lower ... Read more
Cognitive behavioral therapy for pain can lead to an immediate decrease in the use of sleep medications among people with insomnia due to fibromyalgia, a study found. However, such behavioral therapy ... Read more
People with fibromyalgia have poor sleep quality and experience more sleep disturbances than people without the disorder, according to data from a new study. The study, “Comparison of sleep ... Read more
Tonix Pharmaceuticals has finished the essential fed-fasting and dose proportionality tests of its TNX-102 SL investigational therapy in healthy volunteers. The data from these tests are expected to support ... Read more
Patients with chronic fatigue syndrome and fibromyalgia have higher levels of high-sensitivity C-reactive protein (hsCRP) — a marker of inflammation — compared to healthy individuals, a study has found. ... Read more
Following an agreement with Pfizer, Axsome Therapeutics now has exclusive rights to develop and commercialize AXS-14 (esreboxetine) — a drug candidate for treatment of fibromyalgia — in the United ... Read more